ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,391Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 1942

$704K Total Retail Price of All Prescriptions

Rank: 19 out of 1942

377 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 377 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 377 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 9,716 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
WARFARIN SODIUM 432 432 1 11
LEVOTHYROXINE SODIUM 427 409 2 3
PRAVASTATIN SODIUM 419 417 3 23
FUROSEMIDE 405 391 4 5
OMEPRAZOLE 366 340 5 4
POTASSIUM CHLORIDE 301 281 6 17
AMLODIPINE BESYLATE 283 274 7 6
ALENDRONATE SODIUM 273 272 8 21
LISINOPRIL 268 250 9 2
SIMVASTATIN 227 210 10 1
METOPROLOL TARTRATE 190 182 11 9
POLYETHYLENE GLYCOL 3350 178 178 12 28
METOPROLOL SUCCINATE 167 158 13 13
AMLODIPINE BESYLATE-BENAZEPRIL 153 153 14 106
TRAMADOL HCL 148 132 15 19
METFORMIN HCL 129 128 16 10
MIRTAZAPINE 126 105 17 38
NAMENDA 120 106 18 51
CYMBALTA 120 97 18 62
CITALOPRAM HBR 111 97 20 15
DOXAZOSIN MESYLATE 110 110 21 72
DONEPEZIL HCL 110 110 21 30
HYDROCODONE-ACETAMINOPHEN 109 87 S3 23 12
HYDROCHLOROTHIAZIDE 105 103 24 8
PREDNISONE 102 87 25 27
LOSARTAN POTASSIUM 90 90 26 18
ATENOLOL 81 81 27 7
ZETIA 81 57 27 75
SPIRONOLACTONE 80 70 29 59
ALLOPURINOL 78 75 30 26
TRAZODONE HCL 76 76 31 24
ZOLPIDEM TARTRATE 72 51 32 25
GABAPENTIN 71 60 33 16
ADVAIR DISKUS 71 41 33 35
TERAZOSIN HCL 69 69 35 77
SPIRIVA 66 55 36 57
CRESTOR 65 61 37 34
LOVASTATIN 63 63 38 32
LANSOPRAZOLE 60 60 39 125
PANTOPRAZOLE SODIUM 60 51 39 48
GLIMEPIRIDE 59 59 41 53
LACTULOSE 58 58 42 120
ABILIFY 57 56 43 155
ISOSORBIDE MONONITRATE ER 57 53 43 42
AZITHROMYCIN 56 47 45 43
ATENOLOL-CHLORTHALIDONE 56 56 45 115
FLUTICASONE PROPIONATE 55 52 47 37
LOSARTAN-HYDROCHLOROTHIAZIDE 54 54 48 67
BENAZEPRIL HCL 54 54 48 158
LYRICA 52 52 50 144
SERTRALINE HCL 52 43 50 20
VYTORIN 50 50 52 284
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.